当前位置：
X-MOL 学术
›
Physiol. Rev.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
REPLY TO THORNELOE ET AL.
Physiological Reviews ( IF 29.9 ) Pub Date : 2017-10-01 , DOI: 10.1152/physrev.00020.2017 John P. M. White 1 , Mario Cibelli 1 , Laszlo Urban 1 , Bernd Nilius 1 , Graham McGeown 1 , Istvan Nagy 1
Physiological Reviews ( IF 29.9 ) Pub Date : 2017-10-01 , DOI: 10.1152/physrev.00020.2017 John P. M. White 1 , Mario Cibelli 1 , Laszlo Urban 1 , Bernd Nilius 1 , Graham McGeown 1 , Istvan Nagy 1
Affiliation
to the editor: At the outset, we are, of course, happy to correct the molecular representation, and referencing, of the GSK drugs mentioned in [FIGURE 7][1], as follows:
![Figure][2]![Figure][2]
Thornloe and colleagues complain that we have failed to recognize the efficacy of
中文翻译：
回复到THORNELOE ET AL。
致编辑：首先，我们当然很乐意更正[图7] [1]中提到的GSK药物的分子表示和引用，如下所示：！[图] [2]！[图] [2] Thornloe及其同事抱怨我们未能认识到
更新日期：2017-08-17
中文翻译：
回复到THORNELOE ET AL。
致编辑：首先，我们当然很乐意更正[图7] [1]中提到的GSK药物的分子表示和引用，如下所示：！[图] [2]！[图] [2] Thornloe及其同事抱怨我们未能认识到
京公网安备 11010802027423号